Bankruptcy judge clears $7.4bn Purdue Pharma opioid settlement
The deal could end a years-long legal battle over the OxyContin maker's role in the US opioid crisis.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
